Position in SIGA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$39,890
-$194,770 QoQ
Shares Held
10,959
-75.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#116
of 160 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SIGA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $845,206,958 across 34 Drug Manufacturers - Specialty & Generic names. SIGA ranks #33 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
340,275 | $184,371,197 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
3,316,358 | $136,070,166 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
553,068 | $93,214,076 | |
| 4 | VTRS |
Viatris Inc
|
5,658,439 | $89,856,006 | |
| 5 | ZTS |
Zoetis Inc.
|
912,367 | $65,562,688 | |
| 6 | ALKS |
Alkermes plc.
|
1,170,242 | $61,320,679 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
2,950,225 | $52,986,040 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
2,844,583 | $41,218,006 |
All Filings in SIGA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,890 | 10,959 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $234,660 | 43,862 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $367,405 | 60,132 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $734,185 | 80,239 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $480,920 | 73,761 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $403,743 | 73,676 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $448,320 | 74,596 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $310,371 | 45,981 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $345,912 | 45,575 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $170,908 | 19,966 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $151,944 | 27,133 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $102,080 | 19,444 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $248,368 | 49,182 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $156,618 | 27,238 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $199,985 | 27,172 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $148,515 | 14,419 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $216,499 | 18,696 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $100,698 | 14,203 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $105,158 | 13,984 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $101,989 | 13,801 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $86,261 | 13,736 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $80,613 | 12,402 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $85,393 | 11,746 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $80,695 | 11,746 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||